MAR 02, 2026 5:00 AM PST

Advancing Rare Disease Research Through Genomics Automation

SPONSORED BY: Agilent

For laboratories dedicated to advancing genetic analysis and rare disease research, from cardiogenetics and neurodevelopmental disorders to neuromuscular diseases and hemoglobinopathies, precision, efficiency, and reliability are essential. To meet these demands, this team embraced automation and standardization to simplify their sequencing workflow and ensure consistent, high-quality results.

In this testimonial, hear how collaboration with Agilent helped them streamline complex processes, reduce hands-on time, and deliver faster, more confident answers across a wide range of rare disease research applications. Their experience reflects how Agilent empowers laboratories to focus on what truly matters, improving outcomes through trusted genomic insights.

To learn more, download this free eBook: Automated NGS Solutions Advance Rare Disease Research

About the Sponsor
Agilent (www.agilent.com) is a leader in life sciences, clinical research, diagnostics and applied chemical markets. With over 11,000 employees worldwide, the company provides laboratories worldwide with instruments, services, consumables, applications and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted...
READ MORE
You May Also Like
Loading Comments...